[1]
|
Lauwerys, B. and Houssiau, F. (1998) Cytokines: Clues to the pathogenesis of SLE. Lupus, 7, 211-213.
doi:10.1191/096120398678920136
|
[2]
|
Karonitsch, T., Feierl, E., Steiner, C., et al. (2009) Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mono- nuclear cells. Arthritis Rheum, 60, 1463-1471.
doi:10.1002/art.24449
|
[3]
|
Lee, H., Mima, T., Sugino, H., et al. (2009) Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus. Arthritis Res Ther, 11, 1.
|
[4]
|
Kjeldsen, L., Bainton, D., Sengel?v, H., et al. (1994) Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood, 83, 799-807.
doi:10.1080/00365510802150158
|
[5]
|
Devarajan, P. (2008) Neutrophil gelatinase-associated lipocalin (NGAL): A new marker of kidney disease. Scandinavian journal of clinical and laboratory investigation, 241, 89-94.
|
[6]
|
Pitashny, M., Schwartz, N., Qing, X., et al. (2007) Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum, 56, 1894-1903.
|
[7]
|
Nakano, S., Morimoto, S., Suzuki, J., et al. (2008) Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythe- matosus. Rheumatology, 47, 145-149.
|
[8]
|
Hemmi, H., Takeuchi, O., Kawai, T., et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature, 408, 740-745. doi:10.1038/35047123
|
[9]
|
Matsuo, S., Yamazaki, S., Takeshige, K., et al. (2007) Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation. Bio- chemical Journal, 405, 605-615.
doi:10.1042/BJ20061797
|
[10]
|
Hochberg, M. (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 40, 1725. doi:10.1002/art.1780400928
|
[11]
|
Bombardier, C., Gladman, D., Urowitz, M., et al. (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 35, 630-640.
|
[12]
|
Levey, A., Bosch, J., Lewis, J., et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Annals of Internal Medicine, 130, 461-470.
|
[13]
|
Weening, J., D'Agati, V., Schwartz, M., et al. (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney International, 65, 521- 530. doi:10.1111/j.1523-1755.2004.00443.x
|
[14]
|
Chan, R., Lai, F., Li, E., et al. (2007) Intrarenal cytokine gene expression in lupus nephritis. Annals of the Rheumatic Diseases, 66, 886-892.
|
[15]
|
Wang, G., Lai, F., Lai, K., et al. (2009) Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy. American Journal of Nephrology, 29, 524- 531. doi:10.1159/000185629
|
[16]
|
Chan, R., Lai, F., Li, E., et al. (2004) Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum, 50, 2882-2890.
|
[17]
|
Chan, T., Li, F., Tang, C., et al. (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou nephrology study group. The New England Journal of Medicine, 343, 1156-1162. doi:10.1056/NEJM200010193431604
|
[18]
|
Brunner, H., Mueller, M., Rutherford, C., et al. (2006) Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum, 54, 2577-2584.
doi:10.1002/art.22008
|
[19]
|
Bolignano, D., Coppolino, G., Campo, S., et al. (2008) Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant, 23, 414-416.
|
[20]
|
Hinze, C., Suzuki, M., Klein-Gitelman, M., et al. (2009) Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset sys- temic lupus erythematosus disease activity. Arthritis Rheum, 60, 2772-2781. doi:10.1002/art.24751
|
[21]
|
Machida, H., Ito, S., Hirose, T., et al. (2010) Expression of Toll-like receptor 9 in renal podocytes in child- hood-onset active and inactive lupus nephritis. Nephrol Dial Transplant, 25, 2430-2537.
|
[22]
|
Benigni, A., Caroli, C., Longaretti, L., et al. (2007) Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. Arthritis Rheum, 56, 1569-1578.
|
[23]
|
Papadimitraki, E., Tzardi, M., Bertsias, G., et al. (2009) Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response. Lupus, 18, 831-835. doi:10.1177/0961203309103054
|
[24]
|
Leadbetter, E., Rifkin, I., Hohlbaum, A., et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 416, 603-607. doi:10.1038/416603a
|
[25]
|
Mortensen, E., Fenton, K. and Rekvig, O. (2008) Lupus nephritis: the central role of nucleosomes revealed. American Journal of Pathology, 172, 275-283.
|
[26]
|
Patole, P., Pawar, R., Lech, M., et al. (2006) Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant, 21, 3062-3073.
doi:10.1093/ndt/gfl336
|
[27]
|
Means, T., Latz, E., Hayashi, F., et al. (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. Journal of Clinical Investigation, 115, 407-417.
|